These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34125824)

  • 1. SARS-CoV-2: basic concepts, origin and treatment advances.
    Santos-López G; Cortés-Hernández P; Vallejo-Ruiz V; Reyes-Leyva J
    Gac Med Mex; 2021; 157(1):84-89. PubMed ID: 34125824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19.
    Yadav R; Chaudhary JK; Jain N; Chaudhary PK; Khanra S; Dhamija P; Sharma A; Kumar A; Handu S
    Cells; 2021 Apr; 10(4):. PubMed ID: 33917481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor utilization of angiotensin-converting enzyme 2 (ACE2) indicates a narrower host range of SARS-CoV-2 than that of SARS-CoV.
    Wang Q; Qiu Y; Li JY; Liao CH; Zhou ZJ; Ge XY
    Transbound Emerg Dis; 2021 May; 68(3):1046-1053. PubMed ID: 32794346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel zoonotic COVID-19 pandemic: An expected global health concern.
    Contini C; Di Nuzzo M; Barp N; Bonazza A; De Giorgio R; Tognon M; Rubino S
    J Infect Dev Ctries; 2020 Mar; 14(3):254-264. PubMed ID: 32235085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in research on ACE2 as a receptor for 2019-nCoV.
    Wu J; Deng W; Li S; Yang X
    Cell Mol Life Sci; 2021 Jan; 78(2):531-544. PubMed ID: 32780149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronavirus biology and replication: implications for SARS-CoV-2.
    V'kovski P; Kratzel A; Steiner S; Stalder H; Thiel V
    Nat Rev Microbiol; 2021 Mar; 19(3):155-170. PubMed ID: 33116300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19: A Worldwide, Zoonotic, Pandemic Outbreak.
    Khan T; Agnihotri K; Tripathi A; Mukherjee S; Agnihotri N; Gupta G
    Altern Ther Health Med; 2020 Aug; 26(S2):56-64. PubMed ID: 32412918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19: from the structure and replication cycle of SARS-CoV-2 to its disease symptoms and treatment.
    Zawilska JB; Lagodzinski A; Berezinska M
    J Physiol Pharmacol; 2021 Aug; 72(4):. PubMed ID: 34987123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].
    Lvov DK; Alkhovsky SV
    Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classical and alternative receptors for SARS-CoV-2 therapeutic strategy.
    Masre SF; Jufri NF; Ibrahim FW; Abdul Raub SH
    Rev Med Virol; 2021 Sep; 31(5):1-9. PubMed ID: 33368788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).
    Nayak SK
    Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of Coronavirus and SARS-CoV-2.
    Malik YA
    Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-silico nucleotide and protein analyses of S-gene region in selected zoonotic coronaviruses reveal conserved domains and evolutionary emergence with trajectory course of viral entry from SARS-CoV-2 genomic data.
    Obajuluwa AO; Okiki PA; Obajuluwa TM; Afolabi OB
    Pan Afr Med J; 2020; 37():285. PubMed ID: 33654512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Man-Specific Lectins from Plants, Fungi, Algae and Cyanobacteria, as Potential Blockers for SARS-CoV, MERS-CoV and SARS-CoV-2 (COVID-19) Coronaviruses: Biomedical Perspectives.
    Barre A; Van Damme EJM; Simplicien M; Le Poder S; Klonjkowski B; Benoist H; Peyrade D; Rougé P
    Cells; 2021 Jun; 10(7):. PubMed ID: 34203435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2: a new dimension to our understanding of coronaviruses.
    Araf Y; Faruqui NA; Anwar S; Hosen MJ
    Int Microbiol; 2021 Jan; 24(1):19-24. PubMed ID: 33231780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Origin and Structural Biology of Novel Coronavirus (SARS-CoV-2).
    Mallick R; Duttaroy AK
    Adv Exp Med Biol; 2021; 1352():1-13. PubMed ID: 35132591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of SARS-CoV-2 and its receptor ACE2 with evolutionarily related coronaviruses.
    Li FF; Zhang Q; Wang GY; Liu SL
    Aging (Albany NY); 2020 Nov; 12(21):20938-20945. PubMed ID: 33186121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular evolution and phylogenetic analysis of SARS-CoV-2 and hosts ACE2 protein suggest Malayan pangolin as intermediary host.
    Lopes LR; de Mattos Cardillo G; Paiva PB
    Braz J Microbiol; 2020 Dec; 51(4):1593-1599. PubMed ID: 32592038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxycycline Inhibition of a Pseudotyped Virus Transduction Does Not Translate to Inhibition of SARS-CoV-2 Infectivity.
    Diomede L; Baroni S; De Luigi A; Piotti A; Lucchetti J; Fracasso C; Russo L; Bonaldo V; Panini N; Filippini F; Fiordaliso F; Corbelli A; Beeg M; Pizzato M; Caccuri F; Gobbi M; Biasini E; Caruso A; Salmona M
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.